These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 9022624)

  • 21. [Effect of concentration of circulating luteinizing hormone in late-follicle phase on the outcome of in vitro fertilization for normogonadotrophic women].
    Sun H; Hu Y; Wang B; Chen Q; Zhang N; Chen H; Wang J; Xu Z
    Zhonghua Nan Ke Xue; 2004 Dec; 10(12):912-5. PubMed ID: 15638021
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasma endothelin and LH-RH, LH, FSH, prolactin, progesterone, 17alpha-hydroxyprogesterone, estrone, 17beta-estradiol, delta4-androstenedione, testosterone, active renin, angiotensin-II and ANP levels in blood and LH, estrone and 17beta-estradiol and pregnanediol levels in urine of normal cycling women.
    Usuki S; Kondoh K; Kubo T
    J Cardiovasc Pharmacol; 2000 Nov; 36(5 Suppl 1):S421-7. PubMed ID: 11078439
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Luteinizing hormone concentrations after gonadotropin-releasing hormone antagonist administration do not influence pregnancy rates in in vitro fertilization-embryo transfer.
    Merviel P; Antoine JM; Mathieu E; Millot F; Mandelbaum J; Uzan S
    Fertil Steril; 2004 Jul; 82(1):119-25. PubMed ID: 15236999
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Estrogen replacement therapy in postmenopausal women: a study of the efficacy of estriol and changes in plasma gonadotropin levels.
    Ushiroyama T; Sakai M; Higashiyama T; Ikeda A; Ueki M
    Gynecol Endocrinol; 2001 Feb; 15(1):74-80. PubMed ID: 11293929
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Luteinizing hormone-releasing hormone receptor antagonist may reduce postmenopausal flushing.
    van Gastel P; van der Zanden M; Telting D; Filius M; Bancsi L; de Boer H
    Menopause; 2012 Feb; 19(2):178-85. PubMed ID: 21926922
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The primary level of gonadotropins and the LH-RH test in hypothalamic syndromes in women.
    Baron J; Bućko J; Chwalisz K
    Mater Med Pol; 1980; 12(1-2):110-3. PubMed ID: 6799702
    [No Abstract]   [Full Text] [Related]  

  • 27. Response to LH-RH in women before and after treatment with prednisone.
    Gonzalez-Barcena D; Kastin AJ; Schalch DS; Miller MC; Lee L; Rivas-Llamas R; Schally AV
    Int J Fertil; 1974; 19(2):107-10. PubMed ID: 4371409
    [No Abstract]   [Full Text] [Related]  

  • 28. [The radioimmunological assaying of the luteinizing hormone-releasing hormone (LH-RH) in human beings. A general review (author's transl)].
    Teuwissen B; Thomas K
    J Gynecol Obstet Biol Reprod (Paris); 1981; 10(4):315-33. PubMed ID: 7028854
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human anti-luteinizing hormone-releasing hormone antibodies in patients treated with synthetic luteinizing hormone-releasing hormone.
    Meakin JL; Keogh EJ; Martin CE
    Fertil Steril; 1985 May; 43(5):811-3. PubMed ID: 2860022
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Changes in luteinizing hormone-releasing hormone in human placenta throughout pregnancy.
    Miyake A; Sakumoto T; Aono T; Kawamura Y; Maeda T; Kurachi K
    Obstet Gynecol; 1982 Oct; 60(4):444-9. PubMed ID: 6750474
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effect of ear-acupuncture on the LH-concentration in serum in patients with secondary amenorrhea (author's transl)].
    Kubista E; Boschitsch E; Spona J
    Wien Med Wochenschr; 1981 Mar; 131(5):123-6. PubMed ID: 7233907
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Are LH inhibitors toxic or are they physiologically significant?].
    Talaś M
    Cesk Gynekol; 1967 Aug; 32(6):535-6. PubMed ID: 4869120
    [No Abstract]   [Full Text] [Related]  

  • 33. Immunological castration by a totally synthetic vaccine: modification of biological properties of LH-RH after conjugation to adjuvant-active muramyl peptide.
    Carelli C; Ralamboranto L; Audibert F; Gaillard J; Briquelet N; Dray F; Fafeur V; Haour F; Chedid L
    Int J Immunopharmacol; 1985; 7(2):215-24. PubMed ID: 3891644
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The significance of clinical application of LH-releasing hormone test in patients with amenorrhea (author's transl)].
    Zhang LZ
    Zhonghua Fu Chan Ke Za Zhi; 1981 Oct; 16(4):220-4. PubMed ID: 7044719
    [No Abstract]   [Full Text] [Related]  

  • 35. Explicating hypergonadotropism in postmenopausal women: a statistical model.
    Keenan DM; Veldhuis JD
    Am J Physiol Regul Integr Comp Physiol; 2000 May; 278(5):R1247-57. PubMed ID: 10801294
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Diagnostic use of LH-RH releasing hormone in amenorrhea].
    Mészáros J; Sas M; Morvay J
    Orv Hetil; 1980 Apr; 121(14):813-7. PubMed ID: 6992037
    [No Abstract]   [Full Text] [Related]  

  • 37. Suppression of gonadotropin secretion in the hospitalized postmenopausal female as an effect of acute critical illness.
    van Steenbergen W; Naert J; Lambrecht S; Scheys I; Lesaffre E; Pelemans W
    Neuroendocrinology; 1994 Aug; 60(2):165-72. PubMed ID: 7969774
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Biological effects of an anti-gonadotropin substance present in urine of an impuberal child].
    Berthelay S; Vincent JM; Duvernoy J; Berthelay J
    J Physiol (Paris); 1970; 62 Suppl 3():348-9. PubMed ID: 5515956
    [No Abstract]   [Full Text] [Related]  

  • 39. Safety and Therapeutic Profile of a GnRH-Based Vaccine Candidate Directed to Prostate Cancer. A 10-Year Follow-Up of Patients Vaccinated With Heberprovac.
    Junco JA; Rodríguez R; Fuentes F; Baladrón I; Castro MD; Calzada L; Valenzuela C; Bover E; Pimentel E; Basulto R; Arteaga N; Cid-Arregui A; Sariol F; González L; Porres-Fong L; Medina M; Rodríguez A; Garay AH; Reyes O; López M; de Quesada L; Alvarez A; Martínez C; Marrero M; Molero G; Guerra A; Rosales P; Capote C; Acosta S; Vela I; Arzuaga L; Campal A; Ruiz E; Rubio E; Cedeño P; Sánchez MC; Cardoso P; Morán R; Fernández Y; Campos M; Touduri H; Bacardi D; Feria I; Ramirez A; Cosme K; Saura PL; Quintana M; Muzio V; Bringas R; Ayala M; Mendoza M; Fernández LE; Carr A; Herrera L; Guillén G
    Front Oncol; 2019; 9():49. PubMed ID: 30859088
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anti-GnRH antibodies can induce castrate levels of testosterone in patients with advanced prostate cancer.
    Simms MS; Scholfield DP; Jacobs E; Michaeli D; Broome P; Humphreys JE; Bishop MC
    Br J Cancer; 2000 Aug; 83(4):443-6. PubMed ID: 10945488
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.